Panagora Asset Management Inc Vertex Pharmaceuticals Inc Transaction History

Panagora Asset Management Inc

  • $21 Billion
  • Q4 2024

A detailed history of Panagora Asset Management Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Panagora Asset Management Inc holds 3,425 shares of VRTX stock, worth $1.68 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,425
Previous 13,335 74.32%
Holding current value
$1.68 Million
Previous $6.2 Million 77.76%
% of portfolio
0.01%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$396.64 - $516.74 $3.93 Million - $5.12 Million
-9,910 Reduced 74.32%
3,425 $1.38 Million
Q3 2024

Nov 13, 2024
SELL
$460.0 - $505.78 $16.2 Million - $17.8 Million
-35,219 Reduced 72.54%
13,335 $6.2 Million
Q2 2024

Jul 29, 2024
SELL
$392.81 - $485.53 $20.3 Million - $25.1 Million
-51,616 Reduced 51.53%
48,554 $22.8 Million
Q1 2024

May 07, 2024
SELL
$407.69 - $446.08 $54.6 Million - $59.8 Million
-133,961 Reduced 57.22%
100,170 $41.9 Million
Q4 2023

Feb 08, 2024
BUY
$343.0 - $410.68 $11.2 Million - $13.4 Million
32,612 Added 16.18%
234,131 $95.3 Million
Q3 2023

Oct 31, 2023
BUY
$338.18 - $362.46 $35.7 Million - $38.3 Million
105,608 Added 110.11%
201,519 $70.1 Million
Q2 2023

Aug 11, 2023
BUY
$314.42 - $351.91 $19 Million - $21.3 Million
60,495 Added 170.81%
95,911 $33.8 Million
Q1 2023

May 11, 2023
SELL
$283.23 - $323.1 $21.4 Million - $24.4 Million
-75,526 Reduced 68.08%
35,416 $11.2 Million
Q4 2022

Feb 13, 2023
BUY
$285.76 - $321.48 $9.97 Million - $11.2 Million
34,885 Added 45.87%
110,942 $32 Million
Q3 2022

Nov 14, 2022
SELL
$273.83 - $305.53 $6,024 - $6,721
-22 Reduced 0.03%
76,057 $22 Million
Q2 2022

Aug 15, 2022
SELL
$234.96 - $292.55 $25.6 Million - $31.9 Million
-108,918 Reduced 58.88%
76,079 $21.4 Million
Q1 2022

May 12, 2022
SELL
$221.42 - $260.97 $19.8 Million - $23.3 Million
-89,263 Reduced 32.55%
184,997 $48.3 Million
Q4 2021

Feb 10, 2022
SELL
$177.01 - $223.45 $20.5 Million - $25.8 Million
-115,628 Reduced 29.66%
274,260 $60.2 Million
Q3 2021

Nov 10, 2021
BUY
$181.39 - $202.99 $16.5 Million - $18.5 Million
90,980 Added 30.44%
389,888 $70.7 Million
Q2 2021

Aug 11, 2021
BUY
$187.49 - $221.1 $13.4 Million - $15.8 Million
71,477 Added 31.43%
298,908 $60.3 Million
Q1 2021

May 12, 2021
BUY
$207.02 - $241.31 $38.4 Million - $44.7 Million
185,337 Added 440.29%
227,431 $48.9 Million
Q4 2020

Feb 10, 2021
SELL
$207.01 - $276.09 $10.3 Million - $13.8 Million
-49,947 Reduced 54.27%
42,094 $9.95 Million
Q3 2020

Nov 13, 2020
BUY
$255.65 - $303.1 $3.67 Million - $4.35 Million
14,368 Added 18.5%
92,041 $25 Million
Q2 2020

Aug 12, 2020
BUY
$225.48 - $295.8 $21,871 - $28,692
97 Added 0.13%
77,673 $22.5 Million
Q1 2020

May 14, 2020
SELL
$199.77 - $247.81 $110,472 - $137,038
-553 Reduced 0.71%
77,576 $18.5 Million
Q4 2019

Feb 12, 2020
SELL
$166.71 - $223.91 $30.5 Million - $40.9 Million
-182,691 Reduced 70.04%
78,129 $17.1 Million
Q3 2019

Nov 12, 2019
SELL
$166.23 - $187.09 $79.6 Million - $89.6 Million
-478,708 Reduced 64.73%
260,820 $44.2 Million
Q2 2019

Aug 09, 2019
SELL
$164.61 - $190.37 $19.2 Million - $22.2 Million
-116,764 Reduced 13.64%
739,528 $136 Million
Q1 2019

May 15, 2019
SELL
$163.73 - $194.7 $78.5 Million - $93.4 Million
-479,597 Reduced 35.9%
856,292 $158 Million
Q4 2018

Feb 14, 2019
SELL
$151.91 - $192.21 $18 Million - $22.8 Million
-118,675 Reduced 8.16%
1,335,889 $221 Million
Q3 2018

Nov 13, 2018
BUY
$167.73 - $192.74 $83.7 Million - $96.2 Million
499,019 Added 52.22%
1,454,564 $280 Million
Q2 2018

Aug 14, 2018
BUY
$145.72 - $169.96 $10.7 Million - $12.5 Million
73,360 Added 8.32%
955,545 $162 Million
Q1 2018

May 15, 2018
BUY
$151.6 - $177.13 $9.33 Million - $10.9 Million
61,554 Added 7.5%
882,185 $144 Million
Q4 2017

Feb 14, 2018
BUY
$137.28 - $155.55 $8.55 Million - $9.69 Million
62,303 Added 8.22%
820,631 $123 Million
Q3 2017

Nov 14, 2017
BUY
$148.13 - $162.24 $112 Million - $123 Million
758,328
758,328 $115 Million

Others Institutions Holding VRTX

# of Institutions
1,757
Shares Held
228M
Call Options Held
1.63M
Put Options Held
1.47M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $126B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email